Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Carmistin The Food Company has secured financing of approximately €500 million to continue investments in agriculture and the food industry through a partnership with a bank syndicate.
Romanian construction company Bog'Art has published its 2024 Sustainability Report, marking the second year the company voluntarily reports on its ESG performance.
Fitch Ratings has affirmed its Long-Term Issuer Default Rating of BBB- with a negative outlook for Romanian state-owned nuclear power company Nuclearelectrica.
Nyerges & Partners advised Jinko Power Technology on its entry into the Romanian market through the acquisition of a 50 MW photovoltaic plant combined with a 150 MWh battery energy storage system (BESS) in Olt, southern Romania.
Griffes has leased 6,000 sqm of office space in Unirii View, one of Bucharest's Class A office buildings. Of the total space leased, 2,000 sqm represents new tenants, while three existing tenants expanded their operations.